Although CRTAP mutations were first identified more than a decade ago, little is known about the cellular aspect of the disease mechanism in type VII OI, besides a decrease in CRTAP transcripts, CRTAP and P3H1 protein, and a lack of 3-hydroxylation. This evidence concerns the gene P3H1 and osteogenesis imperfecta type 7.